Skip to main content

Foster James C's Form 4 filing

Charles River Laboratories International, Inc. (CRL) · filed Aug 10, 2021

Accession no.
0001127602-21-023425
Filed
Aug 10, 2021
Trade date
Aug 6, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions. Open-market sales total $4.02M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Foster James CCIK 0001141722Director, Officer (Chairman, President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 6, 2021Common StockGGiftDisposed−2,500$0.00$0212,299Direct
Aug 6, 2021Common StockSSaleDisposed−3,822$400.89F1−$1,532,201.58208,477Direct
Aug 6, 2021Common StockSSaleDisposed−3,718$401.77F2−$1,493,780.86204,759Direct
Aug 6, 2021Common StockSSaleDisposed−1,552$402.71F3−$625,005.92203,207Direct
Aug 6, 2021Common StockSSaleDisposed−808$403.92F4−$326,367.36202,399Direct
Aug 6, 2021Common StockSSaleDisposed−100$405.00−$40,500202,299Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

his transaction was executed in multiple trades at prices ranging from $400.31 to $401.305. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F2

This transaction was executed in multiple trades at prices ranging from $401.31 to $402.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $402.33 to $403.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $403.385 to $404.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)